Benzeno Sharon

Officer at ADPT

Sold, on record
$29.7M
Dollars the filings state
Form 4 sales
33
Latest Jun 29, 2026
Form 144 notices
7
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • ADPTAdaptive Biotechnologies CorpOfficer

Sales by reason

1
Routine
0
Plan not stated
1
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale ADPTRoutine
    Nov 21, 2025 2025

    Sold 606,402 shares at $16.73 ($10.1M)

    Benzeno Sharon, Chief Commercial Ofc Imm Med

    10b5-1 planSold 67.1% of holdings ($15.1M position)296,791 shares leftFollows a Form 144Filing

  2. 2 Form 144 notice ADPTNotice
    Dec 4, 2025 +13 days

    Filed to sell 12,604 shares ($216k)

    Benzeno Sharon, Officer

    10b5-1 plan0.3x usual sizeFiling

  3. 3 Form 4 sale ADPTRoutine
    Dec 4, 2025 same day

    Sold 12,604 shares at $16.85 ($212k)

    Benzeno Sharon, Chief Commercial Ofc Imm Med

    10b5-1 planSold 4.1% of holdings ($5.2M position)296,791 shares left0.3x usual sizeFollows a Form 144Filing

  4. 4 Form 4 sale ADPTNo plan
    Mar 11, 2026 +97 days

    Sold 63,103 shares at $13.17 ($831k)

    Benzeno Sharon, Chief Commercial Ofc Imm Med

    No 10b5-1 planSold 18.8% of holdings ($4.4M position)272,751 shares left1.4x usual sizeFiling

  5. 5 Form 144 notice ADPTNotice
    Mar 16, 2026 +5 days

    Filed to sell 63,103 shares ($916k)

    Benzeno Sharon, Officer

    No 10b5-1 plan1.2x usual sizeFiling

  6. 6 Form 144 notice ADPTNotice
    Jun 26, 2026 +102 days

    Filed to sell 12,871 shares ($261k)

    Benzeno Sharon, Officer

    10b5-1 plan0.2x usual sizeFiling

  7. 7 Form 144 notice ADPTNotice
    Jun 29, 2026 +3 days

    Filed to sell 152,931 shares ($3.2M)

    Benzeno Sharon, Officer

    10b5-1 plan2.8x usual sizeFiling

  8. 8 Form 4 sale ADPTUnusual
    Jun 29, 2026 same day

    Sold 165,802 shares at $21.13 ($3.5M)

    Benzeno Sharon, Chief Commercial Ofc Imm Med

    10b5-1 planSold 42.8% of holdings ($8.2M position)221,278 shares left3.1x usual sizeFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (40)

Form 144 notices and Form 4 sales by Benzeno Sharon
Source
Jun 29, 2026Jun 30, 2026ADPTChief Commercial Ofc Imm MedForm 4 sale165,802$3.5M42.8%UnusualSEC
Jun 29, 2026Jun 29, 2026ADPTOfficerForm 144 notice152,931$3.2MNoticeSEC
Jun 26, 2026Jun 26, 2026ADPTOfficerForm 144 notice12,871$261kNoticeSEC
Mar 16, 2026Mar 16, 2026ADPTOfficerForm 144 notice63,103$916kNoticeSEC
Mar 11, 2026Mar 13, 2026ADPTChief Commercial Ofc Imm MedForm 4 sale63,103$831k18.8%No planSEC
Dec 4, 2025Dec 8, 2025ADPTChief Commercial Ofc Imm MedForm 4 sale12,604$212k4.1%RoutineSEC
Dec 4, 2025Dec 4, 2025ADPTOfficerForm 144 notice12,604$216kNoticeSEC
Nov 21, 2025Nov 24, 2025ADPTChief Commercial Ofc Imm MedForm 4 sale606,402$10.1M67.1%RoutineSEC
Nov 21, 2025Nov 21, 2025ADPTOfficerForm 144 notice308,837$5MNoticeSEC
Nov 20, 2025Nov 20, 2025ADPTOfficerForm 144 notice201,993$3.1MNoticeSEC
Nov 19, 2025Nov 19, 2025ADPTOfficerForm 144 notice95,932$1.3MNoticeSEC
Mar 5, 2025Mar 6, 2025ADPTChief Commercial Ofc Imm MedForm 4 sale44,665$312k10.2%No planSEC
Mar 5, 2024Mar 6, 2024ADPTChief Commercial Ofc Imm MedForm 4 sale29,390$101k8.2%No planSEC
Mar 6, 2023Mar 8, 2023ADPTChief Commercial Ofc Imm MedForm 4 sale11,749$101k5.0%Plan not statedSEC
Mar 7, 2022Mar 8, 2022ADPTChief Business Development OffForm 4 sale2,670$32k2.5%Plan not statedSEC
Mar 15, 2021Mar 17, 2021ADPTChief Business Development OffForm 4 sale1,354$56k5.6%Plan not statedSEC
Mar 1, 2021Mar 3, 2021ADPTChief Business Development OffForm 4 sale6,771$390k100.0%UnusualSEC
Feb 19, 2021Mar 3, 2021ADPTChief Business Development OffForm 4 sale416$25k100.0%UnusualSEC
Feb 16, 2021Feb 17, 2021ADPTChief Business Development OffForm 4 sale16,250$1.1M100.0%UnusualSEC
Feb 1, 2021Feb 3, 2021ADPTChief Business Development OffForm 4 sale6,770$377k100.0%UnusualSEC
Jan 19, 2021Jan 20, 2021ADPTChief Business Development OffForm 4 sale417$29k100.0%UnusualSEC
Jan 4, 2021Jan 6, 2021ADPTChief Business Development OffForm 4 sale6,771$389k100.0%UnusualSEC
Dec 21, 2020Dec 23, 2020ADPTChief Business Development OffForm 4 sale417$25k100.0%UnusualSEC
Dec 1, 2020Dec 2, 2020ADPTChief Business Development OffForm 4 sale6,770$331k100.0%UnusualSEC
Nov 19, 2020Nov 23, 2020ADPTChief Business Development OffForm 4 sale416$20k100.0%UnusualSEC
Nov 2, 2020Nov 4, 2020ADPTChief Business Development OffForm 4 sale6,772$309k100.0%UnusualSEC
Oct 19, 2020Oct 20, 2020ADPTChief Business Development OffForm 4 sale417$21k100.0%UnusualSEC
Oct 1, 2020Oct 2, 2020ADPTChief Business Development OffForm 4 sale6,771$329k100.0%UnusualSEC
Sep 21, 2020Sep 23, 2020ADPTChief Business Development OffForm 4 sale417$19k100.0%UnusualSEC
Sep 1, 2020Sep 2, 2020ADPTChief Business Development OffForm 4 sale6,771$280k100.0%UnusualSEC
Aug 19, 2020Aug 19, 2020ADPTChief Business Development OffForm 4 sale416$17k100.0%UnusualSEC
Aug 4, 2020Aug 5, 2020ADPTChief Business Development OffForm 4 sale7,187$287k100.0%UnusualSEC
Jul 20, 2020Jul 21, 2020ADPTChief Business Development OffForm 4 sale417$17k100.0%UnusualSEC
Jul 1, 2020Jul 2, 2020ADPTChief Business Development OffForm 4 sale6,771$321k100.0%UnusualSEC
Jun 26, 2020Jul 1, 2020ADPTChief Business Development OffForm 4 sale417$20k100.0%UnusualSEC
Jun 26, 2020Jun 30, 2020ADPTChief Business Development OffForm 4 sale417$20k100.0%UnusualSEC
Jun 19, 2020Jun 23, 2020ADPTChief Business Development OffForm 4 sale417$19k100.0%UnusualSEC
Jun 3, 2020Jun 5, 2020ADPTChief Business Development OffForm 4 sale6,770$271k100.0%UnusualSEC
May 26, 2020May 28, 2020ADPTChief Business Development OffForm 4 sale416$17k100.0%UnusualSEC
May 19, 2020May 21, 2020ADPTChief Business Development OffForm 4 sale246,770$9.9M100.0%UnusualSEC